Insights On Pharmaceutical Production

31. The Smart, Savvy Science Driving Viral Vector Scale-Up 4/8/2024

    Learn about cutting-edge strategies, including alternatives to plasmid-based transient transfection, aimed at addressing current process challenges and bringing revolutionary treatments to patients in need.

32. Analysis Of Atorvastatin As Per USP Monograph 9/18/2024

    The USP monograph of atorvastatin requires adherence to strict criteria for the assay analysis of atorvastatin. In this study, several strategies were implemented to meet the stipulated USP monograph criteria.

33. Benefit From Leveraging Perfusion Early In Process Development 4/5/2024

    By addressing the complex needs of cell culture from the start, organizations can take steps to optimize their process, ensuring they are maximizing productivity and product quality.

34. Risk Mitigation For Late-Stage Clinical Assets 6/11/2025

    Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.

35. Design, Operation, And Automation In Aseptic Filling Systems 6/17/2024

    Learn about a modular and compact filling and closing system for flexibility in pharmaceutical manufacturing operations and automated processing of vials, syringes, and cartridges.

36. Multi-Tiered Classification For Downstream Process Intensification 10/31/2024

    Watch to learn about the various levels of intensification, core technologies used in the industry, and the impact of each level on productivity through a monoclonal antibody (mAb) platform.

37. Depth Filters For The Clarification Of AAV 11/27/2024

    Explore study results demonstrating the ability of Sartoclear® depth filters to deliver high performance for AAV clarification, ensuring scalability, high recovery rates, and robust filtration.

38. Optimizing DPI Production: Filling Technologies For Precision And Performance 4/16/2025

    Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.

39. 9 Essential Oligosynthesis Component Needs 4/16/2025

    Meeting the growing need for oligonucleotides means having the right tools. Learn about the nine indispensable components, such as synthesis columns and C&D systems, for your facility.

40. Addressing Raw Material Handling Challenges By Dry Granulation 8/12/2025

    Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.